Sample Page

Scott D. Halpern is an American critical care and palliative care physician at Penn Medicine, and the John M. Eisenberg Professor in Medicine and Professor of Epidemiology and of Medical Ethics and Health Policy at the University of Pennsylvania’s Perelman School of Medicine. He is also the Founding Director of the Palliative and Advanced Illness Research (PAIR) Center at the University of Pennsylvania (Penn).[1] In 2024, Halpern was elected to the National Academy of Medicine for his research examining ways to improve care for seriously ill patients and their families.[2]

Early life and education

Halpern grew up in Springfield, NJ, and graduated from the Pingry School in 1991, where he was a 3-sport varsity athlete. He earned his Bachelor of Science in Psychology and Economics from Duke University in 1995, where he was also the Health and Science Editor of The Chronicle.[3] In 2003, he became the first student to earn a combined MD/PhD in Epidemiology from Penn, also earning a Master of Bioethics (MBe) during this time. Halpern completed clinical training at the Hospital of the University of Pennsylvania (HUP) in Internal Medicine, Critical Care Medicine, and Palliative Medicine.[4]

Early research career

Halpern’s Ph.D. Dissertation in Epidemiology and Biostatistics focused on the design and ethics of randomized clinical trials and earned Penn’s Saul Winegrad Award for outstanding dissertation.[5] Much of his scholarship as a post-doctoral fellow and junior faculty member focused on ways to improve the supply[6][7][8] and allocation[9][10] of transplantable organs. He penned analyses of controversial transplant practices,[11][12][13][14] including specific cases such as the Sarah Murnaghan lung transplant controversy.[15]

Extending the theme of how best to allocate scarce health care resources, Halpern next developed the construct of and coined the term “ICU capacity strain”[16]—i.e., the causes and consequences of limits on a hospital unit’s ability to deliver high-quality care to all patients who could benefit from it at a given time. The construct has been adopted by investigators around the world to understand how care changes when ICUs and hospitals get busy.[17] Additional work from Halpern’s research group showed that ICU readmission rates are not attributable to the quality of ICU care,[18][19] contributing to Medicare’s decision to abandon its plan to develop ICU readmission rate as a quality measure.[20]

In 2011, Halpern was named the Deputy Director of the Center for Health Incentives and Behavioral Economics (CHIBE) at Penn, led by Kevin Volpp, applying behavioral economic principles to some of the most pressing challenges in preventive health care.[21] With Volpp, Halpern conducted some of the largest trials ever in the field of smoking cessation.[22][23]

Motivated by the premature death of his father, Richard Halpern, in 2009,[24] Halpern in 2012 founded the Fostering Improvement in End-of-Life Decision Science (FIELDS) program, the nation’s first program specifically applying behavioral economic principles to the delivery of end-of-life care for seriously ill patients.[25] Halpern’s scholarship through the FIELDS program was recognized that same year when the Robert Wood Johnson Foundation selected him and 9 others to receive its inaugural Young Leader Award, given to “leaders ages 40 and under for their exceptional contributions to improving the health of the nation.”[26] In addition to empirical work demonstrating that the ways in which end-of-life decisions are framed heavily influence the choices seriously ill patients make,[27][28][29] Halpern has addressed the foundational ethical issues raised by “nudging” patients’ healthcare choices.[30]

Halpern has challenged the serious illness care field to apply the same level of analytic rigor to studying interventions as is required for new-drug development.[31][32] He is also known for prominent analyses of other critical topics in end-of-life care, including advance directives and physician orders for life-sustaining therapy,[33][34][35] goal-concordant care,[36] medical aid in dying,[37] and health states patients consider worse than death.[38]

Subsequent research

In 2017, Halpern established the Palliative and Advanced Illness Research (PAIR) Center. The mission of the PAIR Center is to “generate high-quality evidence to advance healthcare policies and practices with the goals of improving the lives of all people affected by serious illness and removing the barriers to health equity that seriously ill patients commonly face.”[39]

Within the PAIR Center, Halpern and his team have studied how patients and clinicians communicate and make decisions around serious illness care, including how they predict future outcomes.[40][41][42] His team conducts clinical trials testing scalable interventions to improve care, including conducting some of the largest trials ever in the field of palliative care delivery.[43][44][45]

Additionally, Halpern works to promote fairness in clinical care delivery[46] and reduce bias in clinical prediction models.[47] He also works to improve the representativeness of clinical trials[48][49] through the Behavioral Economics to Transform Trial Enrollment Representativeness Center,[50] which Halpern founded in 2022 with funding from the American Heart Association’s strategically focused research network on the science of diversity in clinical trials.[51]

During the COVID-19 pandemic, Halpern was also featured by news outlets across the country[52][53][54] for his clinical work in ICUs, scholarship on the supply and allocation of beds and ventilators,[55][56] and his contributions to ethics guidelines for the allocation of such resources that were adopted by hospitals across Pennsylvania.[57]

Mentorship

Halpern serves as the Principal Investigator of the nation’s only training grant in Critical Care Health Policy Research (T32HL098054)[58] and is the recipient of an NIH Midcareer Investigator Award in Patient-Oriented Research (K24HL143289),[59] which provides dedicated time to support his mentorship. In addition to training postdoctoral fellows and early-career faculty, Halpern has mentored medical, graduate, and undergraduate students for more than 15 years.[60] He has been recognized with the John Hansen-Flaschen Award for Outstanding Mentorship and the Arthur K. Asbury Outstanding Faculty Mentor Award from the University of Pennsylvania.[61]

Awards and honors

References

  1. ^ “The Palliative and Advanced Illness Research Center”. The PAIR Center.
  2. ^ “National Academy of Medicine Elects 100 New Members”. National Academy of Medicine. 21 October 2024.
  3. ^ “Scott Halpern”. The Chronicle. 13 June 1996.
  4. ^ “Scott D. Halpern, MD, PhD, M.Bioethics”. Perelman School of Medicine.
  5. ^ “Saul Winegrad Award for Outstanding Dissertation Recipients 1995 – Present” (PDF). Perelman School of Medicine. Retrieved 16 April 2026.
  6. ^ Halpern, Scott (December 15, 2010). “Estimated supply of organ donors after circulatory determination of death: a population-based cohort study”. JAMA. 304 (23): 2592–2594. doi:10.1001/jama.2010.1824. PMID 21156947.
  7. ^ Halpern, Scott (March 16, 2010). “Regulated payments for living kidney donation: an empirical assessment of the ethical concerns”. Annals of Internal Medicine. 152 (10): 358–365. doi:10.7326/0003-4819-152-6-201003160-00005. PMC 2865248. PMID 20231566.
  8. ^ “The ethics of paying kidney donors”. WHYY. March 17, 2010.
  9. ^ Munson, Jeffrey (August 25, 2011). “The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease”. American Journal of Respiratory and Critical Care Medicine. 184 (11): 1282–1288. doi:10.1164/rccm.201104-0695OC. PMC 3262042. PMID 21868502.
  10. ^ Thabut, Gabriel (July 7, 2010). “Survival differences following lung transplantation among US transplant centers”. JAMA. 304 (1): 53–60. doi:10.1001/jama.2010.885. PMID 20606149.
  11. ^ Halpern, Scott (July 25, 2002). “Solid-organ transplantation in HIV-infected patients”. New England Journal of Medicine. 347 (4): 284–287. doi:10.1056/NEJMsb020632. PMID 12140307.
  12. ^ Halpern, Scott (June 26, 2008). “Informing candidates for solid-organ transplantation about donor risk factors”. New England Journal of Medicine. 358 (26): 2832–2837. doi:10.1056/NEJMsb0800674. PMID 18579820.
  13. ^ Halpern, Scott (January 26, 2017). “Allocating Organs to Cognitively Impaired Patients”. New England Journal of Medicine. 376 (4): 299–301. doi:10.1056/NEJMp1613858. PMID 28121499.
  14. ^ Truog, Robert (October 3, 2013). “The dead-donor rule and the future of organ donation”. New England Journal of Medicine. 369 (14): 1287–1289. doi:10.1056/NEJMp1307220. PMID 24088088.
  15. ^ Halpern, Scott (September 3, 2013). “Turning wrong into right: the 2013 lung allocation controversy”. Annals of Internal Medicine. 159 (5): 358–359. doi:10.7326/0003-4819-159-5-201309030-00684. PMID 23797998.
  16. ^ Halpern, Scott (December 1, 2011). “ICU capacity strain and the quality and allocation of critical care”. Current Opinion in Critical Care. 17 (6): 648–657. doi:10.1097/MCC.0b013e32834c7a53. PMID 21986461.
  17. ^ Rewa, Oleksa (March 27, 2018). “Indicators of intensive care unit capacity strain: A systematic review”. Critical Care. 22 (1) 86. doi:10.1186/s13054-018-1975-3. PMC 5870068. PMID 29587816.
  18. ^ Brown, Sydney (May 1, 2012). “The epidemiology of intensive care unit readmissions in the United States”. American Journal of Respiratory and Critical Care Medicine. 185 (9): 955–964. doi:10.1164/rccm.201109-1720oc. PMC 3359937. PMID 22281829.
  19. ^ Brown, Sydney (August 1, 2013). “An empirical derivation of the optimal time interval for defining ICU readmissions”. Medical Care. 51 (8): 706–714. doi:10.1097/MLR.0b013e318293c2fa. PMC 3714373. PMID 23698182.
  20. ^ “Summary Report of the Technical Expert Panel Meeting, April 2013 (Deliverable #20)” (PDF). CMS.gov. Retrieved 7 April 2026.
  21. ^ Halpern, Scott (September 27, 2007). “Harnessing the power of default options to improve health care”. New England Journal of Medicine. 357 (13): 1340–1344. doi:10.1056/NEJMsb071595. PMID 17898105.
  22. ^ Halpern, Scott (May 13, 2015). “Randomized trial of four financial-incentive programs for smoking cessation”. New England Journal of Medicine. 372 (22): 2108–2117. doi:10.1056/nejmoa1414293. PMC 4471993. PMID 25970009.
  23. ^ Halpern, Scott (May 23, 2018). “A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation”. New England Journal of Medicine. 378 (24): 2302–2310. doi:10.1056/NEJMsa1715757. PMID 29791259.
  24. ^ Halpern, Scott. “What is behavioral economics? Can it advance the care of seriously ill patients?”. Retrieved 7 April 2026.
  25. ^ Halpern, Scott (December 1, 2012). “Employing behavioral economics and decision science in crucial choices at end of life”. Health Affairs. 31 (12): 2789–2790. doi:10.1377/hlthaff.2012.1107. PMID 23174815.
  26. ^ “Honors and other things” (PDF). Almanac. Vol. 59, no. 11. University of Pennsylvania. November 6, 2012. Retrieved 7 April 2026.
  27. ^ Halpern, Scott (February 1, 2013). “Default options in advance directives influence how patients set goals for end-of-life care”. Health Affairs. 32 (2). doi:10.1377/hlthaff.2012.0895. PMC 4445426. PMID 23381535.
  28. ^ Courtright, Katherine (August 10, 2016). “A Randomized Trial of Expanding Choice Sets to Motivate Advance Directive Completion”. Medical Decision Making. 37 (5). doi:10.1177/0272989×16663709. PMID 27510741.
  29. ^ Josephs, Michael (February 20, 2018). “Active Choice Intervention Increases Advance Directive Completion: A Randomized Trial”. Medical Decision Making – Policy & Practice. 3 (1). doi:10.1177/2381468317753127. PMID 30288436.
  30. ^ Gorin, Moti (March 1, 2017). “Justifying Clinical Nudges”. Hastings Center Report. 47 (2). doi:10.1002/hast.688. PMID 28301695.
  31. ^ Halpern, Scott (November 19, 2015). “Toward Evidence-Based End-of-Life Care”. New England Journal of Medicine. 373 (21). doi:10.1056/NEJMp1509664. PMID 26465826.
  32. ^ Burling, Stacey (May 22, 2016). “Making end-of-life care more scientific”. The Philadelphia Inquirer. Retrieved 10 April 2026.
  33. ^ Rolnick, Joshua (June 1, 2017). “Delegalizing Advance Directives – Facilitating Advance Care Planning”. New England Journal of Medicine. 376 (22). doi:10.1056/nejmp1700502. PMID 28564570.
  34. ^ Halpern, Scott (February 3, 2015). “Can the United States buy better advance care planning?”. Annals of Internal Medicine. 162 (3). doi:10.7326/m14-2476. PMID 25486099.
  35. ^ Moore, Kendra (January 19, 2016). “The Problems With Physician Orders for Life-Sustaining Treatment”. JAMA. 315 (3). doi:10.1001/jama.2015.17362. PMID 26754769.
  36. ^ Halpern, Scott (October 24, 2019). “Goal-Concordant Care – Searching for the Holy Grail”. New England Journal of Medicine. 381 (17). doi:10.1056/nejmp1908153. PMID 31644843.
  37. ^ Halpern, Scott (February 4, 2021). “Learning about End-of-Life Care from Grandpa”. New England Journal of Medicine. 384 (5). doi:10.1056/nejmp2026629. PMID 33085883.
  38. ^ Rubin, Emily (October 1, 2016). “States Worse Than Death Among Hospitalized Patients With Serious Illnesses”. JAMA Internal Medicine. 176 (10). doi:10.1001/jamainternmed.2016.4362. PMID 27479808.
  39. ^ “About the PAIR Center”. The PAIR Center.
  40. ^ Detsky, Michael (June 6, 2017). “Discriminative Accuracy of Physician and Nurse Predictions for Survival and Functional Outcomes 6 Months After an ICU Admission”. JAMA. 317 (21). doi:10.1001/jama.2017.4078. PMID 28528347.
  41. ^ Rubin, Emily (January 4, 2019). “Intuitive vs Deliberative Approaches to Making Decisions About Life Support: A Randomized Clinical Trial”. JAMA Network Open. 2 (1). doi:10.1001/jamanetworkopen.2018.7851. PMC 6484534. PMID 30681717.
  42. ^ Hart, Joanna (November 1, 2023). “Accuracy of expected symptoms and subsequent quality of life measures among adults with COPD”. JAMA Network Open. 6 (11). doi:10.1001/jamanetworkopen.2023.44030. PMC 10663971. PMID 37988080.
  43. ^ Courtright, Katherine (January 16, 2024). “Default palliative care consultation for seriously ill hospitalized patients: A pragmatic cluster-randomized trial”. JAMA. 331 (3). doi:10.1001/jama.2023.25092. PMC 10792472. PMID 38227032.
  44. ^ Raeke, Meagan (January 16, 2024). “A scalable strategy to increase inpatient palliative care”. Penn Medicine News. Retrieved 10 April 2026.
  45. ^ Courtright, Katherine (May 1, 2025). “Nudging Clinicians to Promote Serious Illness Communication for Critically Ill Patients: A Pragmatic Cluster-Randomized Trial”. JAMA Internal Medicine. 185 (5). doi:10.1001/jamainternmed.2025.0090. PMID 40094649.
  46. ^ Chesley, Christopher (December 1, 2022). “Characterizing Equity of Intensive Care Unit Admissions for Sepsis and Acute Respiratory Failure”. Annals of the American Thoracic Society. 19 (12). doi:10.1513/annalsats.202202-115oc. PMC 9743468. PMID 35830576.
  47. ^ Ashana, Deepshikha (July 15, 2021). “Equitably Allocating Resources during Crises: Racial Differences in Mortality Prediction Models”. American Journal of Respiratory and Critical Care Medicine. 204 (2). doi:10.1164/rccm.202012-4383oc. PMC 8759151. PMID 33751910.
  48. ^ Schwartz, Aaron (April 6, 2023). “Why Diverse Clinical Trial Participation Matters”. New England Journal of Medicine. 388 (14). doi:10.1056/nejmp2215609. PMID 37017480.
  49. ^ Zaman, Mirel (March 30, 2026). “Clinical Trials (Still) Have a Race Problem. Where Do We Go From Here?”. HealthCentral. Retrieved 10 April 2026.
  50. ^ “BETTER Center: Behavioral Economics to Transform Trial Enrollment Representativeness Center”. The PAIR Center.
  51. ^ Michos, Erin (October 7, 2025). “Evaluating the Science of Diversity in Clinical Trials: Design and Goals of an American Heart Association Strategic Focused Research Network”. Journal of the American Heart Association. 14 (19). doi:10.1161/JAHA.125.041831. PMID 40996051.
  52. ^ Abdelmalek, Mark (March 25, 2020). “As coronavirus pandemic surges, hospitals prepare for grim possibility of ‘ventilator triage’. ABC News. Retrieved 10 April 2026.
  53. ^ Said, Carolyn (April 4, 2020). “Which coronavirus patients get ventilators, and how will California hospitals decide?”. San Francisco Chronicle. Retrieved 10 April 2026.
  54. ^ “Doctors worry they will be forced into life-or-death decisions amid virus pandemic: ‘I’m not God’. CBS News. April 8, 2020. Retrieved 10 April 2026.
  55. ^ Halpern, Scott (August 18, 2020). “The Urge to Build More Intensive Care Unit Beds and Ventilators: Intuitive but Errant”. Annals of Internal Medicine. 173 (4). doi:10.7326/m20-2071. PMC 7224606. PMID 32379853.
  56. ^ Weissman, Gary (October 20, 2020). “Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic”. Annals of Internal Medicine. 173 (8). doi:10.7326/l20-1062. PMID 33075245.
  57. ^ White, Douglas; Halpern, Scott. “Allocation of Scarce Critical Care Resources During a Public Health Emergency” (PDF). Institute for Bioethics. University of Pittsburgh. Retrieved 10 April 2026.
  58. ^ “Training in Critical Care Health Policy Research”. NIH RePORTER. Retrieved 10 April 2026.
  59. ^ “Improving the fairness of RCTs among patients with acute and chronic respiratory failure”. NIH RePORTER. Retrieved 10 April 2026.
  60. ^ Levins, Hoag (January 28, 2025). “Penn LDI Receives $3.5 Million Gift from the Son of Its Founding Benefactor”. Penn LDI. Retrieved 10 April 2026.
  61. ^ “Announcing 2019 Penn Medicine Awards of Excellence”. Office of the Dean. Perelman School of Medicine. Retrieved 10 April 2026.
  62. ^ “Scott David Halpern”. National Academy of Medicine. Retrieved 10 April 2026.
  63. ^ “J Randall Curtis Humanism Award”. American Thoracic Society. Retrieved 10 April 2026.